Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Terminated 7Recruiting 7Unknown 4Not yet recruiting 3Suspended 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 86Bevacizumab 66Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 40Drug Therapy 39Leucovorin 38sintilimab 35Irinotecan 34lenvatinib 27Cisplatin 27HMPL-013 25S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20130-nm albumin-bound paclitaxel 20toripalimab 19Paclitaxel 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14regorafenib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Interleukin-2 × Gastrointestinal × Clear all
NCT06504875 2024-07-17

Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer

The First Affiliated Hospital with Nanjing Medical University

Not yet recruiting
23 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06504901 2024-07-17

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

The First Affiliated Hospital with Nanjing Medical University

Not yet recruiting
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05810792 2023-11-22

PANCEP-1

Sahlgrenska University Hospital

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡